Cognition Therapeutics, Inc. (CGTX) vs MediciNova, Inc. (MNOV)
A side-by-side comparison of Cognition Therapeutics, Inc. and MediciNova, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGTX
Cognition Therapeutics, Inc.
$0.94HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
MNOV
MediciNova, Inc.
$1.67HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — CGTX vs MNOV
growth of $100 · dividends reinvested · last 5yCGTX -92.7% (-40.7%/yr)MNOV -52.0% (-13.7%/yr)MNOV compounded faster over this window
Log scale — wide-divergence pair
CGTX MNOV
CGTX vs MNOV: by the numbers
- •CGTX is the larger company ($84M vs $82M market cap).
- •Both run net losses; CGTX's is the smaller (0.00% vs -1168.20% net margin).
Metrics side by side
Valuation
| Metric | CGTX | MNOV |
|---|---|---|
| P/S ratio | N/A | 89.31 |
| P/B ratio | 2.55 | 2.21 |
Profitability
| Metric | CGTX | MNOV |
|---|---|---|
| Gross margin | 0.00% | 7.58% |
| Operating margin | 0.00% | -3242.47% |
| Net margin | 0.00% | -1168.20% |
| ROE | -50.80% | -28.85% |
| ROIC | -109.43% | -31.62% |
Growth (annualized)
| Metric | CGTX | MNOV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -25.46% |
| Total return CAGR (5Y) | N/A | -13.62% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.